英国首次新冠疫情高峰对重度哮喘患者的影响。哪个更糟糕：病毒还是封锁措施？
The impact of the first COVID-19 surge on severe asthma patients in the UK. Which is worse: the virus or the lockdown?
作者信息
Smith Steven J, Busby John, Heaney Liam G, Pfeffer Paul E, Jackson David J, Yang Freda, Fowler Stephen J, Menzies-Gow Andrew, Idris Elfatih, Brown Thomas, Gore Robin, Faruqi Shoaib, Dennison Paddy, Dodd James W, Doe Simon, Mansur Adel H, Priyadarshi Radhika, Holmes Joshua, Hearn Andrew, Al-Aqqad Hamsa, Loewenthal Lola, Cooper Angela, Fox Lauren, Selvan Mayurun, Crooks Michael G, Thompson Alison, Higbee Daniel, Fawdon Michelle, Nathwani Vishal, Holmes LeanneJo, Chaudhuri Rekha
机构信息
Gartnavel General Hospital and University of Glasgow, Glasgow, UK.
Queen's University, Belfast, UK.
出版信息
ERJ Open Res. 2021 Feb 1;7(1). doi: 10.1183/23120541.00768-2020. eCollection 2021 Jan.
Abstract
摘要
https://bit.ly/3jImUsG. （链接无法直接翻译，保留原文）
相似文献
1
The impact of the first COVID-19 surge on severe asthma patients in the UK. Which is worse: the virus or the lockdown?英国首次新冠疫情高峰对重度哮喘患者的影响。哪个更糟糕：病毒还是封锁措施？
ERJ Open Res. 2021 Feb 1;7(1). doi: 10.1183/23120541.00768-2020. eCollection 2021 Jan.
2
Negative impact of the first COVID-19 lockdown upon health-related behaviours and psychological wellbeing in people living with severe and complex obesity in the UK.英国首次新冠疫情封锁对严重和复杂肥胖患者健康相关行为及心理健康的负面影响。
EClinicalMedicine. 2021 Apr;34:100796. doi: 10.1016/j.eclinm.2021.100796. Epub 2021 Mar 18.
3
Pre-COVID-19 lung function and other risk factors for severe COVID-19 in first responders.新冠疫情前急救人员的肺功能及其他严重新冠疫情风险因素。
ERJ Open Res. 2021 Jan 25;7(1). doi: 10.1183/23120541.00610-2020. eCollection 2021 Jan.
4
Impact of COVID-19 on COPD and asthma admissions, and the pandemic from a patient's perspective.从患者角度看2019冠状病毒病对慢性阻塞性肺疾病和哮喘住院情况的影响以及疫情
ERJ Open Res. 2021 Feb 8;7(1). doi: 10.1183/23120541.00822-2020. eCollection 2021 Jan.
5
Is asthma a risk factor for COVID-19? Are phenotypes important?哮喘是新冠病毒病的一个风险因素吗？表型重要吗？
ERJ Open Res. 2021 Jan 25;7(1). doi: 10.1183/23120541.00216-2020. eCollection 2021 Jan.
6
Impact of COVID-19 shielding on physical activity and quality of life in patients with COPD.新型冠状病毒肺炎防护措施对慢性阻塞性肺疾病患者身体活动及生活质量的影响
Breathe (Sheff). 2020 Sep;16(3):200231. doi: 10.1183/20734735.0231-2020.
7
COVID-19 in patients with pulmonary alveolar proteinosis: a European multicentre study.肺泡蛋白沉积症患者的新型冠状病毒肺炎：一项欧洲多中心研究
ERJ Open Res. 2023 Jan 3;9(1). doi: 10.1183/23120541.00199-2022. eCollection 2023 Jan.
8
The Incidence and Severity of COVID-19 in the Liverpool Severe Asthma Population Undergoing Biologic Therapy.接受生物治疗的利物浦重症哮喘患者中新冠病毒病的发病率和严重程度
Cureus. 2022 Sep 5;14(9):e28790. doi: 10.7759/cureus.28790. eCollection 2022 Sep.
9
The polyhedric reality of the interaction between COVID-19, asthma and inhaled corticosteroids.新型冠状病毒肺炎、哮喘与吸入性糖皮质激素之间相互作用的多面现实
ERJ Open Res. 2022 May 30;8(2). doi: 10.1183/23120541.00179-2022. eCollection 2022 Apr.
10
Air quality in Mexico City during the COVID-19 lockdown possibly decreased COPD exacerbations.在新冠疫情封锁期间，墨西哥城的空气质量可能降低了慢性阻塞性肺疾病（COPD）的急性加重发生率。
ERJ Open Res. 2022 Oct 10;8(4). doi: 10.1183/23120541.00183-2022. eCollection 2022 Oct.
引用本文的文献
1
Incident and recurrent depression among older adults with asthma during the COVID-19 pandemic: Findings from the Canadian Longitudinal Study on Aging.COVID-19 大流行期间老年哮喘患者的偶发和复发性抑郁：来自加拿大老龄化纵向研究的结果。
Respir Med. 2023 Jul;213:107003. doi: 10.1016/j.rmed.2022.107003. Epub 2023 Jan 12.
2
Safety of biological therapy in children and adolescents with severe asthma during the COVID-19 pandemic: a case series.COVID-19 大流行期间严重哮喘儿童和青少年使用生物疗法的安全性：病例系列。
Acta Biomed. 2022 Jun 6;93(S3):e2022053. doi: 10.23750/abm.v93iS3.13073.
3
COVID-19 in the absence of eosinophils: The outcome of confirmed SARS-CoV-2 infection whilst on treatment with benralizumab.无嗜酸性粒细胞情况下的COVID-19：接受贝那利珠单抗治疗期间确诊的SARS-CoV-2感染的结果
Allergy. 2022 Aug;77(8):2558-2560. doi: 10.1111/all.15334. Epub 2022 May 11.
4
Rhinovirus Infections and Their Roles in Asthma: Etiology and Exacerbations.鼻病毒感染及其在哮喘中的作用：病因和加重。
J Allergy Clin Immunol Pract. 2022 Mar;10(3):673-681. doi: 10.1016/j.jaip.2022.01.006. Epub 2022 Jan 22.
5
Understanding and Managing Severe Asthma in the Context of COVID-19.在2019冠状病毒病背景下理解和管理重度哮喘
Immunotargets Ther. 2021 Dec 11;10:419-430. doi: 10.2147/ITT.S342636. eCollection 2021.
6
Health-related quality of life, uncertainty and coping strategies in solid organ transplant recipients during shielding for the COVID-19 pandemic.COVID-19 大流行期间实体器官移植受者屏蔽期的健康相关生活质量、不确定性和应对策略。
Transpl Int. 2021 Nov;34(11):2122-2137. doi: 10.1111/tri.14010. Epub 2021 Sep 16.
7
Asthma and COVID-19: a dangerous liaison?哮喘与2019冠状病毒病：危险关联？
Asthma Res Pract. 2021 Jul 15;7(1):9. doi: 10.1186/s40733-021-00075-z.
8
Asthma did not increase in-hospital COVID-19-related mortality in a tertiary UK hospital.在英国一家三级医院中，哮喘并未增加与新冠肺炎相关的院内死亡率。
Clin Exp Allergy. 2021 Jul;51(7):939-941. doi: 10.1111/cea.13855. Epub 2021 Mar 2.
9
Impact of COVID-19 on COPD and asthma admissions, and the pandemic from a patient's perspective.从患者角度看2019冠状病毒病对慢性阻塞性肺疾病和哮喘住院情况的影响以及疫情
ERJ Open Res. 2021 Feb 8;7(1). doi: 10.1183/23120541.00822-2020. eCollection 2021 Jan.
本文引用的文献
1
The Inhaled Steroid Ciclesonide Blocks SARS-CoV-2 RNA Replication by Targeting the Viral Replication-Transcription Complex in Cultured Cells.吸入性类固醇 Ciclesonide 通过靶向细胞培养中的病毒复制转录复合物来阻断 SARS-CoV-2 RNA 复制。
J Virol. 2020 Dec 9;95(1). doi: 10.1128/JVI.01648-20.
2
Inhaled corticosteroids in virus pandemics: a treatment for COVID-19?病毒大流行中的吸入性糖皮质激素：治疗新型冠状病毒肺炎（COVID-19）的方法？
Lancet Respir Med. 2020 Sep;8(9):846-847. doi: 10.1016/S2213-2600(20)30314-3. Epub 2020 Jul 30.
3
COVID-19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments.意大利重症哮喘网络（SANI）患者中的新型冠状病毒肺炎：临床特征、合并症的影响及治疗情况
Allergy. 2021 Mar;76(3):887-892. doi: 10.1111/all.14532. Epub 2020 Aug 20.
4
Dexamethasone in Hospitalized Patients with Covid-19.地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
5
Factors associated with COVID-19-related death using OpenSAFELY.使用 OpenSAFELY 分析与 COVID-19 相关死亡的因素。
Nature. 2020 Aug;584(7821):430-436. doi: 10.1038/s41586-020-2521-4. Epub 2020 Jul 8.
6
Early experiences of SARS-CoV-2 infection in severe asthmatics receiving biologic therapy.接受生物治疗的重度哮喘患者感染新型冠状病毒2的早期经历。
J Allergy Clin Immunol Pract. 2020 Sep;8(8):2784-2786. doi: 10.1016/j.jaip.2020.06.027. Epub 2020 Jun 24.
7
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.使用 ISARIC WHO 临床特征协议住院的 20133 例英国新冠患者的特征：前瞻性观察队列研究。
BMJ. 2020 May 22;369:m1985. doi: 10.1136/bmj.m1985.
8
Viral infections in allergy and immunology: How allergic inflammation influences viral infections and illness.过敏与免疫学中的病毒感染：过敏性炎症如何影响病毒感染及疾病
J Allergy Clin Immunol. 2017 Oct;140(4):909-920. doi: 10.1016/j.jaci.2017.07.025.
9
The influence of asthma control on the severity of virus-induced asthma exacerbations.哮喘控制对病毒诱发的哮喘急性加重严重程度的影响。
J Allergy Clin Immunol. 2015 Aug;136(2):497-500.e3. doi: 10.1016/j.jaci.2015.01.028. Epub 2015 Mar 13.
Zotero 插件